Stock FUM FUTURA MEDICAL PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Futura Medical plc

Equities

FUM

GB0033278473

Biotechnology & Medical Research

Market Closed - London S.E.
Other stock markets
 11:35:25 2024-04-26 am EDT 		5-day change 1st Jan Change
35.45 GBX +0.14% Intraday chart for Futura Medical plc -0.56% +39.02%
Apr. 10 Futura Medical hails results as erectile dysfunction drug drives sales AN
Apr. 10 Transcript : Futura Medical plc, 2023 Earnings Call, Apr 10, 2024

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 12.58 28.4 37.46 112.9 147.5 106.9 106.9 -
Enterprise Value (EV) 1 12.58 28.4 36.44 102.5 143.5 69.14 103.9 100.9
P/E ratio - - -15.4 x -21.5 x -25.2 x - -34.8 x 42.7 x
Yield - - - - - - - -
Capitalization / Revenue - 894 x - - - 24.8 x 11.2 x 6.5 x
EV / Revenue - 894 x - - - 22.3 x 10.9 x 6.14 x
EV / EBITDA - - -12,550,676 x -17,528,053 x -20,952,058 x - -101,387,063 x 25,468,736 x
EV / FCF - - -8.01 x -23.9 x -22 x -73.9 x -23.1 x 27.3 x
FCF Yield - - -12.5% -4.19% -4.54% -1.35% -4.33% 3.66%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 204,583 204,660 245,627 287,151 288,047 301,449 301,449 -
Reference price 2 0.0615 0.1388 0.1525 0.3930 0.5120 0.3545 0.3545 0.3545
Announcement Date 4/10/19 4/1/20 4/14/21 4/26/22 4/5/23 4/10/24 - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 - 0.0318 - - - 3.101 9.518 16.43
EBITDA - - -2.903 -5.846 -6.847 - -1.025 3.96
EBIT 1 - - -2.928 -5.866 -6.871 -6.964 -3.128 2.226
Operating Margin - - - - - -224.57% -32.86% 13.55%
Earnings before Tax (EBT) 1 - - -2.927 -5.866 -6.871 -6.892 -2.796 2.339
Net income -5.881 - -2.408 -4.958 -5.846 - -3.072 2.497
Net margin - - - - - - -32.28% 15.2%
EPS - - -0.009900 -0.0183 -0.0203 - -0.0102 0.008300
Free Cash Flow 1 - - -4.552 -4.293 -6.516 -0.9356 -4.498 3.695
FCF margin - - - - - -30.17% -47.26% 22.49%
FCF Conversion (EBITDA) - - - - - - - 93.3%
FCF Conversion (Net income) - - - - - - - 147.99%
Dividend per Share 2 - - - - - - - -
Announcement Date 4/10/19 4/1/20 4/14/21 4/26/22 4/5/23 4/10/24 - -
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - - - -
Net Cash position 1 - - 1.02 10.4 4.03 7.71 2.94 5.99
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - -4.55 -4.29 -6.52 -0.94 -4.5 3.7
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex - - 0.01 0.42 0.74 - 1.98 0.49
Capex / Sales - - - - - - 20.79% 2.99%
Announcement Date 4/10/19 4/1/20 4/14/21 4/26/22 4/5/23 4/10/24 - -
1GBP in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.3545 GBP
Average target price
1.263 GBP
Spread / Average Target
+256.37%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
FUTURA MEDICAL PLC Stock Futura Medical plc
+39.02% 133M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.74B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. FUM Stock
  4. Financials Futura Medical plc